Buy & Sell Enveric Biosciences Inc (ENVB) – Enveric Biosciences Inc Price Today
Aura AI Summary
Enveric Biosciences (ENVB) is a biotechnology stock trading at $1.82, down 22.55% in the last session. The company has consistently beaten earnings expectations, including a surprise profit in Q4 2025, and recently secured a $13.9 million private placement to fund its pipeline of neuroplastogenic therapeutics. Analyst sentiment is predominantly bullish, with a 75% buy rating, but the stock faces significant volatility and high negative profitability ratios.
The outlook hinges on clinical progress and cash runway extension from recent financing. Investment opportunity lies in the speculative upside of its novel drug pipeline, particularly for psychiatric disorders. Key risks include the pre-revenue biotech model, substantial cash burn reflected in negative ROE and ROA, and dependence on dilutive financing, which pressures shareholder value amid high stock price volatility.
Key Stats
- $3.43MMarket Cap
- HealthSector
- -59.59%3M Drawdown
- -$1.25MEnterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 0 daysTypical Hold Time
52W Low: $1.79
30 Mar 2026
52W High: $17.4
27 Aug 2025
Enveric Biosciences Inc (ENVB) is currently valued at a market capitalization of $3.43M, with an enterprise value of -$1.25M. Over the past 52 weeks, Enveric Biosciences Inc has traded between a low of $1.79 and a high of $17.4, highlighting its annual price range. Over the past three months, Enveric Biosciences Inc has recorded a drawdown of -59.59%, reflecting recent price volatility. On average, investors hold Enveric Biosciences Inc for approximately 0 days, indicating typical investor behavior on the platform.
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Technical Indicators
|
|
|
Overall Summary
Bearish (7)Neutral (6)Bullish (10)
News
People also bought
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions